B
Bernard Tardy
Researcher at French Institute of Health and Medical Research
Publications - 101
Citations - 5651
Bernard Tardy is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Thrombosis & Heparin-induced thrombocytopenia. The author has an hindex of 27, co-authored 94 publications receiving 4740 citations. Previous affiliations of Bernard Tardy include University of Lyon & Jean Monnet University.
Papers
More filters
Journal ArticleDOI
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
Hervé Decousus,Alain Leizorovicz,Florence Parent,Y. Page,Bernard Tardy,Philippe Girard,Silvy Laporte,René Faivre,Bernard Charbonnier,Fabrice-Guy Barral,Yann Huet,Gérald Simonneau +11 more
TL;DR: In high-risk patients with proximal deep-vein thrombosis, the initial beneficial effect of vena caval filters for the prevention of pulmonary embolism was counterbalanced by an excess of recurrent deep-vesin thROMBosis, without any difference in mortality.
Journal ArticleDOI
Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic.
Maelle Detoc,S. Bruel,Paul Frappé,Bernard Tardy,Elisabeth Botelho-Nevers,Amandine Gagneux-Brunon,Amandine Gagneux-Brunon,Amandine Gagneux-Brunon +7 more
TL;DR: The proportion of people who intend to get vaccinated against COVID-19 in France or to participate in a vaccine clinical trial was determined and vaccine hesitancy was associated with refusal for participation in a CO VID-19 vaccineclinical trial.
Journal ArticleDOI
Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: a cross sectional survey.
Amandine Gagneux-Brunon,Maelle Detoc,Sébastien Bruel,Bernard Tardy,Olivier Rozaire,Paul Frappe,Elisabeth Botelho-Nevers +6 more
TL;DR: Intention to get vaccinated against COVID-19 reached 75% in HCWs with discrepancies between occupational categories, and CO VID-19 pandemic had no positive effect on flu vaccine acceptance rate.
Journal ArticleDOI
Prevention of Venous Thromboembolism in Internal Medicine with Unfractionated or Low-molecular-weight Heparins: A Meta-analysis of Randomised Clinical Trials
Patrick Mismetti,Silvy Laporte-Simitsidis,Bernard Tardy,Michel Cucherat,Andrea Buchmuller,Daphné Juillard-Delsart,Hervé Decousus +6 more
TL;DR: This meta-analysis of randomised trials studying prophylactic unfractionated and low-molecular-weight heparin in internal medicine shows that heparins are beneficial in the prevention of venous thromboembolism in internal Medicine.
Journal ArticleDOI
Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial.
Patrick Mismetti,Silvy Laporte,Olivier Pellerin,Pierre-Vladimir Ennezat,Francis Couturaud,Antoine Elias,Nicolas Falvo,Nicolas Meneveau,Isabelle Quéré,Pierre-Marie Roy,Olivier Sanchez,Jeannot Schmidt,Christophe Seinturier,Marie-Antoinette Sevestre,Jean-Paul Beregi,Bernard Tardy,Philippe Lacroix,Emilie Presles,Alain Leizorovicz,Hervé Decousus,Fabrice-Guy Barral,Guy Meyer +21 more
TL;DR: Among hospitalized patients with severe acute pulmonary embolism, the use of a retrievable inferior vena cava filter plus anticoagulation compared with anticogulation alone did not reduce the risk of symptomatic recurrent pulmonary emblism at 3 months, and these findings do not support theUse of this type of filter in patients who can be treated with antICOagulation.